Mobilization of arachidonic acid in thrombin-stimulated human platelets
- 1 February 1990
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 68 (2) , 520-527
- https://doi.org/10.1139/o90-074
Abstract
In the present work we investigated the effect of serine esterase inhibitors such as 2-nitro-4-carboxyphenyl N,N-diphenylcarbamate (NCDC) and phenylmethylsulfonyl fluoride (PMSF), as well as the effect of mepacrine on thrombin-induced mobilization of arachidonic acid (AA) in human platelets. The inhibitor NCDC (0.6 mM) completely abolished the thrombin-induced activation of phospholipase C, phospholipase A2, and transacylase enzymes, whereas the pretreatment of platelets with PMSF (2 mM) resulted in a highly selective inhibition of phospholipase A2 and transacylase activities, with no marked effect on thrombin-induced activation of phospholipase C. The thrombin-induced release of [3H]AA from phosphatidylcholine and phosphatidylinositol was reduced by 90 and 56%, respectively, in the presence of PMSF. This inhibitor also caused a parallel inhibition in the accumulation of [3H]AA (85%) with little effect on thrombin-induced formation of [3H]phosphatidic acid (5%), whereas mepacrine (0.4 mM) caused a selective inhibition of phospholipase A2 and transacylase activities with concomitant stimulation of [3H]phosphatidic acid formation in intact human platelets. These results demonstrate that NCDC and PMSF (serine esterase inhibitors) do not affect agonist-induced activation of phospholipases that mobilize arachidonic acid through a common site. Our results further demonstrate that the inhibition of [3H]AA release observed in the presence of NCDC, PMSF, and mepacrine is primarily due to their direct effects on enzyme activities, rather than due to their indirect effects through formation of complexes between inhibitors and membrane phospholipids. Based upon these results, we also conclude that the combined hydrolysis of phosphatidylcholine and phosphatidylinositol by phospholipase A2 serves as a major source for eicosanoid biosynthesis in thrombin-stimulated human platelets.Key words: deacylation, phospholipids, thrombin, platelets, phospholipase A2.This publication has 25 references indexed in Scilit:
- Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets.Journal of Biological Chemistry, 1981
- The phosphatidylinositol cycle and the regulation of arachidonic acid productionNature, 1981
- Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets.Journal of Biological Chemistry, 1981
- Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipaseBiochemical and Biophysical Research Communications, 1981
- Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid.Journal of Biological Chemistry, 1981
- Serine esterase inhibitors block stimulus-induced mobilization of arachidonic acid and phosphatidylinositide-specific phospholipase C activity in platelets.Journal of Biological Chemistry, 1980
- Diglyceride lipase: a pathway for arachidonate release from human platelets.Proceedings of the National Academy of Sciences, 1979
- Production of diglyceride from phosphatidylinositol in activated human platelets.Journal of Clinical Investigation, 1979
- LOCAL-ANESTHETICS, CHLORPROMAZINE AND PROPRANOLOL INHIBIT STIMULUS-ACTIVATION OF PHOSPHOLIPASE-A2 IN HUMAN-PLATELETS1979
- Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.Journal of Clinical Investigation, 1977